STVN Stock: Price, Earnings History and SEC Filings
Stevanato Group S.p.A. (STVN) last traded at $19.38, down 4.25% on the latest session and down 7.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.16 against an analyst estimate of $0.15, a beat of 6.7%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
STVN earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 4, 2026 | $0.16 | $0.15 | +6.67% |
| Mar 2026 | May 7, 2026 | $0.13 | $0.12 | +8.33% |
| Dec 2025 | Mar 4, 2026 | $0.21 | $0.20 | +5.00% |
| Sep 2025 | Nov 6, 2025 | $0.16 | $0.14 | +14.29% |
STVN beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for STVN
Insider filing activity
STVN insiders filed 4 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
STVN news
- Stevanato Group SpaNov 1, 2026 · 247wallst.com
- Stevanato Group S.p.A. (STVN) Rallies on 2Q26 Revenue Growth and EBITDA Margin ExpansionOct 28, 2026 · finance.yahoo.com
- Aptar Pharma and Stevanato Group Collaborate to Help Accelerate Pre-Filled Syringe System SelectionOct 27, 2026 · finance.yahoo.com
- Stevanato Group and Aptar Pharma Collaborate to Help Accelerate Pre-Filled Syringe System SelectionOct 27, 2026 · finance.yahoo.com
- Stevanato Group to Report Third Quarter 2026 Financial Results on November 3, 2026Oct 20, 2026 · finance.yahoo.com
About Stevanato Group S.p.A.
Stevanato Group S.p.A. (STVN) is a US-listed public company on NYSE. The SEC classifies its business as Surgical & Medical Instruments & Apparatus.